ketoconazole has been researched along with rifamycins in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Meyer, C | 1 |
Capoccia, E; Cirillo, C; Cuomo, R; D'Alessandro, A; Esposito, G; Gigli, S; Nobile, N; Pesce, M; Sarnelli, G; Seguella, L; Steardo, L | 1 |
2 other study(ies) available for ketoconazole and rifamycins
Article | Year |
---|---|
A banner year for AIDS therapy.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antitubercular Agents; Atovaquone; HIV Infections; Humans; Itraconazole; Ketoconazole; Naphthoquinones; Rifabutin; Rifamycins; United States; United States Food and Drug Administration; Zalcitabine | 1993 |
Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway.
Topics: Anti-Bacterial Agents; Caco-2 Cells; Cell Movement; Cell Proliferation; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Inflammation; Ketoconazole; Neoplasm Proteins; Neovascularization, Pathologic; Pregnane X Receptor; Proliferating Cell Nuclear Antigen; Receptors, Steroid; Rifamycins; Rifaximin; Signal Transduction | 2016 |